A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost

BACKGROUND: The development of an effective HIV-1 vaccine is critical to control the pandemic. A prime-boost HIV-1 vaccine trial assessing safety and immunogenicity was conducted in Thailand as part of an evaluation of candidate regimens for a phase 3 efficacy trial. METHODS: ALVAC-HIV (vCP1521), ex...

Saved in:

書目詳細資料
Main Authors:	Prasert Thongcharoen, Vinai Suriyanon, Robert M. Paris, Chirasak Khamboonruang, Mark S. De Souza, Silvia Ratto-Kim, Chitraporn Karnasuta, Victoria R. Polonis, Lynn Baglyos, Raphaelle El Habib, Sanjay Gurunathan, Susan Barnett, Arthur E. Brown, Deborah L. Birx, John G. McNeil, Jerome H. Kim
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34848908400&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/61274
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
由: Prasert Thongcharoen, et al.
出版: (2018)

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
由: Punnee Pitisuttithum, et al.
出版: (2018)

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A post-hoc analysis of the Thai phase 3 efficacy trial RV 144
由: Merlin L. Robb, et al.
出版: (2018)

HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
由: Paris R., et al.
出版: (2014)

HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
由: R. Paris, et al.
出版: (2018)

Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: Detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1
由: Jerome H. Kim, et al.
出版: (2018)

P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
由: J. Kaewkungwal, et al.
出版: (2018)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
由: Nicos Karasavvas, et al.
出版: (2018)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
由: Nicos Karasavvas, et al.
出版: (2018)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
由: Nicos Karasavvas, et al.
出版: (2018)

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
由: Supachai Rerks-Ngarm, et al.
出版: (2018)

Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunteers enrolled in an ALVAC-HIV phase I/II prime boost vaccine trial in Thailand
由: Wannee Kantakamalakul, et al.
出版: (2018)

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX ® B/E
由: Robert Paris, et al.
出版: (2018)

Colorimetric Detection by Gold Nanoparticle DNA Probes for Miltenberger Series (GP.Mur, GP.Hop, and GP.Bun) Identification
由: Apirom Vongsakulyanon, et al.
出版: (2018)

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations
由: Siriwat Akapirat, et al.
出版: (2019)

Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide
由: S. Moses Dennison, et al.
出版: (2018)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α<inf>4</inf>β<inf>7</inf>
由: Sakaorat Lertjuthaporn, et al.
出版: (2019)

Glycosylation of gp116 and gp64 envelope proteins of yellow head virus of Penaeus monodon shrimp
由: Chumporn Soowannayan, et al.
出版: (2018)

Vaccine-induced human antibodies specific for the third variable region of HIV-1 gp120 impose immune pressure on infecting viruses
由: Susan Zolla-Pazner, et al.
出版: (2018)

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
由: Chitraporn Karnasuta, et al.
出版: (2018)

Identification and analysis of gp116 and gp64 structural glycoproteins of yellow head nidovirus of Penaeus monodon shrimp
由: Sarawut Jitrapakdee, et al.
出版: (2018)

Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion
由: Munir S. Alam, et al.
出版: (2018)

On quasi pseudo-GP-injective rings and modules
由: Truong Cong Quynh, et al.
出版: (2018)

ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
由: Costanzo M.C.
出版: (2023)

Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection
由: Reynard, O., et al.
出版: (2016)

The Potential of Camellia sinensis Extract to Prevent HIV/AIDS Transmission Risk Through the Inhibition of Syncytium, GP120, and GP41 Formation
由: Retno Pudji Rahayu, et al.
出版: (2019)

Aggregated GP-based Optimization for Contaminant Source Localization
由: Tipaluck Krityakierne, et al.
出版: (2020)

Monadic second-order incorrectness logic for GP 2
由: POSKITT, Christopher M., et al.
出版: (2023)

The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120
由: Nicos Karasavvas, et al.
出版: (2018)

Identification of immunodominant cd4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E
由: Silvia Ratto-Kim, et al.
出版: (2018)

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
由: Sorachai Nitayaphan, et al.
出版: (2018)

Development of HIV-1 fusion inhibitors targeting gp41
由: Lu, K., et al.
出版: (2014)

Simulation cloning on GP-GPU high performance computing systems
由: Akash Jana
出版: (2012)

Grave prognosis on spontaneous intracerebral haemorrhage: GP on stage score
由: Niphon Poungvarin, et al.
出版: (2018)

Analysis of the YHV genome and expression of recombinant glycoprotein GP116
由: Nusra Sittidilokratna
出版: (2023)

Reverse Engineering Pesawat Amphibi Osprey-2 (GP3)
由: BUDHIYAN S, RIO

Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.
由: Ratto-Kim, Silvia, et al.
出版: (2015)

Protein kinase C δ associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp 130 interaction
由: Novotny-Diermayr, V., et al.
出版: (2013)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
由: J. H. Kim, et al.
出版: (2018)

Cloning and expression of ebola virus GP and VP40 structural proteins
由: Lee, Carmen Ching Pei
出版: (2016)